ZERBE ROBERT L MD
Director · VCEL
As of 2026-09-16, ZERBE ROBERT L MD has 13 Form 4 transactions on record across 1 company — 5 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
- Direct $1.3M
- Indirect $0
| VCEL | direct | 32,995 sh | $1.3M |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-05 | VCEL | Sale | 2,500 @ $62.50 | $156K | −8.6% of holding | 26,595 | Form 4 |
12 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-04-29 | VCEL | Award / grant | 3,200 | 3,200 | Form 4 |
| 2026-04-29 | VCEL | Option exercise | 3,200 | 0 | Form 4 |
| 2026-04-29 | VCEL | Award / grant | 8,000 | 8,000 | Form 4 |
| 2026-04-29 | VCEL | Option exercise | 3,200 | 32,995 | Form 4 |
| 2026-04-29 | VCEL | Option exercise | 3,200 | 32,995 | Form 4 |
| 2025-04-30 | VCEL | Award / grant | 3,200 | 3,200 | Form 4 |
| 2025-04-30 | VCEL | Option exercise | 3,200 | 0 | Form 4 |
| 2025-04-30 | VCEL | Award / grant | 8,000 | 8,000 | Form 4 |
| 2025-04-30 | VCEL | Option exercise | 3,200 | 29,795 | Form 4 |
| 2025-04-30 | VCEL | Option exercise | 3,200 | 29,795 | Form 4 |
| 2025-02-05 | VCEL | Option exercise | 2,500 | 29,095 | Form 4 |
| 2025-02-05 | VCEL | Option exercise | 2,500 | 7,500 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.